Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia

Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia

IntroductionCombination of venetoclax and hypomethylating agents (HMAs) has become a standard of care in acute myeloid leukemia (AML) aged >75 years or who have comorbidities that preclude intensive induction chemotherapy.MethodsWe conducted a monocentric retrospective analysis on adult patie...

Full description

Bibliographic Details
Main Authors: Mariarita Sciumè, Alessandro Bosi, Marta Canzi, Giusy Ceparano, Fabio Serpenti, Pasquale De Roberto, Sonia Fabris, Elena Tagliaferri, Francesca Cavallaro, Francesco Onida, Nicola Stefano Fracchiolla
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
venetoclax
acute myeloid leukemia
azacitidine
decitabine
relapse
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1149298/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1149298/full

Similar Items